Robert Schreiber, PhD, the Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been named a co-editor-in-chief of Cancer Immunology Research.
In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one step closer to reality.
Robert Schreiber, PhD, delivered the Stanley J. Korsmeyer Memorial Lecture in May. The annual lecture honors a beloved former Washington University medical oncologist and researcher whose groundbreaking discoveries opened new doors to understanding and treating cancer.
A new center at the School of Medicine will help scientists use the power of the immune system to fight infections and cancers. The Center for Human Immunology and Immunotherapy Programs is part of BioMed21, Washington University’s initiative to accelerate basic science discoveries into improved diagnosis and treatment for patients.
John DiPersio, MD, PhD, chief of the Division of Oncology at Washington University School of Medicine in St. Louis, and Robert Schreiber, PhD, director of the school’s Center for Human Immunology and Immunotherapy Programs, will be honored in April by the American Association for Cancer Research.
Three Washington University in St. Louis scientists are among the 84 members and 21 foreign associates elected to the National Academy of Sciences this year. Election to the academy is considered one of the highest honors that can be accorded a U.S. scientist or engineer.